Disclosures for "The REthinking MeAsures of DivErsity (REMADE) Study: Developing New Diversity Measures to Ensure Fair Representation in Clinical Trials"
-
Dr. Yu has received personal compensation for serving as an employee of Alexion. Dr. Yu has stock in AstraZeneca.
-
Adrian Kielhorn has received personal compensation for serving as an employee of Alexion. Adrian Kielhorn has stock in Alexion.
-
Dr. Murdoch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for M&B Sciences. Dr. Murdoch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for XOME.
-
Dr. Martin has nothing to disclose.
-
Dr. Martin has nothing to disclose.
-
Mrs. McNeil-Posey has received personal compensation for serving as an employee of Alexion Pharma.
-
Dr. Mungin has nothing to disclose.
-
Ms. Xia has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Ms. Xia has stock in Astrazeneca.
-
Mrs. Erler has received personal compensation for serving as an employee of Alexion Astra Zeneca. Mrs. Erler has stock in Alexion Astra Zeneca.
-
Dr. Kurukulasuriya has received personal compensation for serving as an employee of AstaZeneca/Alexion. Dr. Kurukulasuriya has received personal compensation for serving as an employee of AstraZeneca/Alexion. Dr. Kurukulasuriya has stock in AstraZeneca/Alexion. Dr. Kurukulasuriya has stock in AstraZeneca/Alexion.